Immunic (IMUX) Other Operating Expenses (2014 - 2022)

Immunic has disclosed Other Operating Expenses across 5 years of filings, most recently posting $33.0 million for Q4 2022.

• Other Operating Expenses for Q4 2022 came in at $33.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $33.0 million (changed N/A YoY), and the FY2022 annual result was $33.0 million, up 91.13% from the prior year.
• Other Operating Expenses came in at $33.0 million for Q4 2022 at Immunic, up from $17.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $33.0 million in Q4 2022 to a low of -$12.2 million in Q1 2018.
• The 3-year median for Other Operating Expenses is $8.6 million (2018), against an average of $9.5 million.